|
|
|
Insider
Information: |
Baker Felix |
Relationship: |
Director, 10% Owner |
City: |
|
State: |
|
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
927,207 |
|
Indirect Shares
|
141,861,898 |
|
|
Direct
Value |
$82,119,756 |
|
|
Indirect Value
|
$12,961,771,173 |
|
|
Total
Shares |
142,789,105 |
|
|
Total
Value |
$13,043,890,929 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
36
|
6
|
Stock
price went up :
|
15
|
6
|
Stock
price went down : |
21
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
6.0
|
Percentage
Gain/Loss : |
-24.3%
|
18.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Incyte Corp |
INCY |
Director, 10% Owner |
2023-09-29 |
559,963 |
2023-09-29 |
33,480,292 |
Premium* |
|
Ardea Biosciences Inc |
RDEA |
Director, 10% Owner |
2003-10-06 |
0 |
2012-02-01 |
116,454 |
Premium* |
|
Seagen Inc |
SGEN |
Director, 10% Owner |
2018-02-01 |
215,015 |
2018-02-01 |
44,355,335 |
Premium* |
|
Synageva BioPharma Corp |
GEVA |
Director, 10% Owner |
2015-06-22 |
100,503 |
2015-06-22 |
9,328,233 |
Premium* |
|
Viropharma Inc |
VPHM |
10% Owner |
2005-01-31 |
0 |
2011-12-14 |
303,264 |
Premium* |
|
Aceragen, Inc |
ACGN |
Director |
|
0 |
2017-07-03 |
145,453 |
Premium* |
|
Tapestry Pharmaceuticals Inc |
TPPHQ |
10% Owner |
|
0 |
2008-10-15 |
0 |
Premium* |
|
Genomic Health Inc |
GHDX |
Director, 10% Owner |
2012-10-01 |
288 |
2012-10-01 |
11,377,485 |
Premium* |
|
Allos Therapeutics Inc |
ALTH |
10% Owner |
|
0 |
2009-02-06 |
1,629 |
Premium* |
|
Biocryst Pharmaceuticals Inc |
BCRX |
10% Owner |
2016-08-16 |
46,918 |
2016-08-16 |
9,418,390 |
Premium* |
|
Heron Therapeutics Inc |
HRTX |
10% Owner |
|
0 |
2011-06-30 |
5,266,568 |
Premium* |
|
Adolor Corp |
ADLR |
10% Owner |
2010-04-26 |
0 |
2011-12-19 |
0 |
Premium* |
|
Diadexus Inc |
DDXS |
10% Owner |
|
0 |
2010-07-28 |
140,525 |
Premium* |
|
Pharmacyclics Inc |
PCYC |
10% Owner |
|
0 |
2011-08-22 |
1,809 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2012-03-12 |
0 |
2012-03-14 |
57,704 |
Premium* |
|
XOMA Corporation |
XOMA |
Director, 10% Owner |
2012-10-29 |
0 |
2012-10-29 |
480,639 |
Premium* |
|
Neurogene |
NGNE |
10% Owner |
2015-08-07 |
4,520 |
|
0 |
Premium* |
|
Invitae Corp |
NVTA |
10% Owner |
|
0 |
2015-08-27 |
6,554,967 |
Premium* |
|
Bellicum Pharmaceuticals, Inc |
BLCM |
10% Owner |
|
0 |
2015-12-24 |
4,865,647 |
Premium* |
|
Kodiak Sciences Inc. |
KOD |
Director, 10% Owner |
2022-01-21 |
0 |
2022-06-06 |
15,967,504 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
1397 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 37 of 56
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-30 |
4 |
S |
$12.03 |
$213,718 |
I/I |
(17,765) |
1,081,432 |
0 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.97 |
$348,509 |
I/I |
70,100 |
1,090,407 |
1.5 |
- |
|
INCY |
Incyte Corp |
10% Owner |
|
2003-09-22 |
4 |
B |
$4.89 |
$4,890 |
I/I |
1,000 |
1,091,407 |
1.42 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-19 |
4 |
S |
$11.80 |
$16,463 |
I/I |
(1,395) |
1,099,197 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-15 |
4 |
S |
$11.77 |
$311,031 |
I/I |
(26,415) |
1,100,592 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-25 |
4 |
B |
$16.24 |
$680,782 |
I/I |
41,909 |
1,110,832 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-14 |
4 |
S |
$12.05 |
$68,148 |
I/I |
(5,655) |
1,127,007 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-13 |
4 |
S |
$12.02 |
$96,064 |
I/I |
(7,991) |
1,132,662 |
0 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-08 |
4 |
S |
$12.72 |
$131,810 |
I/I |
(10,361) |
1,140,653 |
0 |
- |
|
GEVA |
Synageva BioPharma Corp |
Director |
|
2004-10-13 |
4 |
D |
$0.00 |
$0 |
I/I |
(586,556) |
1,144,755 |
|
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-29 |
4 |
B |
$16.39 |
$561,850 |
I/I |
34,288 |
1,145,120 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-09 |
4 |
B |
$4.00 |
$1,914,744 |
I/I |
478,196 |
1,145,484 |
2.1 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2007-05-30 |
4 |
B |
$16.44 |
$81,953 |
I/I |
4,984 |
1,150,104 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-07 |
4 |
S |
$12.66 |
$617,006 |
I/I |
(48,744) |
1,151,014 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2007-02-14 |
4 |
S |
$8.72 |
$8,718,099 |
I/I |
(999,782) |
1,153,217 |
0 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-04 |
4 |
B |
$13.28 |
$1,011,152 |
I/I |
76,141 |
1,156,516 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2008-04-17 |
4 |
B |
$13.28 |
$146,664 |
I/I |
11,044 |
1,167,560 |
1.5 |
- |
|
RDEA |
Ardea Biosciences Inc |
10% Owner |
|
2007-06-11 |
4 |
OE |
$1.03 |
$171,196 |
I/I |
165,727 |
1,172,221 |
0 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-05 |
4 |
B |
$19.50 |
$449,789 |
I/I |
22,939 |
1,173,043 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-13 |
4 |
B |
$3.90 |
$115,329 |
I/I |
28,825 |
1,174,309 |
2.1 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-19 |
4 |
B |
$4.00 |
$39,555 |
I/I |
9,895 |
1,184,204 |
2.25 |
- |
|
ACGN |
Aceragen, Inc |
10% Owner |
|
2007-11-06 |
4 |
S |
$12.14 |
$746,209 |
I/I |
(61,467) |
1,199,758 |
0 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-20 |
4 |
B |
$3.99 |
$64,366 |
I/I |
16,117 |
1,200,321 |
2.25 |
- |
|
GHDX |
Genomic Health Inc |
Director |
|
2008-06-06 |
4 |
B |
$20.01 |
$760,813 |
I/I |
37,657 |
1,210,700 |
2.25 |
- |
|
SGEN |
Seagen Inc |
Director |
|
2006-06-21 |
4 |
B |
$4.07 |
$49,776 |
I/I |
12,220 |
1,212,541 |
2.25 |
- |
|
1397 Records found
|
|
Page 37 of 56 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|